[Therapy and prophylaxis of recurrent erysipelas (author's transl)].

Abstract

17 patients suffering from chronically recurrent erysipelas were treated through 10 days - every day - with 10 mega Na-penicillin G intravenously, before noon, and with 1.2 mega (900000 units clemizole penicillin G plus 300000 units Na-penicillin G) intramuscularly or 1 to 2 mega penicillin V acid orally, in the afternoon. Thereafter, these patients were to be injected through six months, in two week intervals, a repository penicillin (600000 units benzathine penicillin G, 300000 unmand in a divers manner. During the observation period from 1 7/12 to 2 8/12 years, 11 out of 17 patients remained without relapse. Frequency of recidivation significantly decreased in 3 patients; no improvement was achieved in the three last patients.

• Authors: A Ziebart-Schroth
• Journal: Medizinische Klinik (Med Klin) Vol. 71 Pg. 1197-9 (Jul 09 1976) ISSN: 0025-8458 [Print] Germany
• Vernacular Title: Zur Therapie und Prophylaxe des rezidivierenden Erysipels
• PMID: 822266 (Publication Type: English Abstract, Journal Article)

Chemical References

• Penicillins
• Penicillin G
• Penicillin G Benzathine
• Penicillin V

Topics

• Administration, Oral
• Adult
• Aged
• Drug Therapy, Combination
• Erysipelas (drug therapy, prevention & control)
• Humans
• Injections, Intravenous
• Long-Term Care
• Middle Aged
• Penicillin G (therapeutic use)
• Penicillin G Benzathine (therapeutic use)
• Penicillin V (therapeutic use)
• Penicillins (therapeutic use)
• Recurrence